Longevity Clinics and the Recovery Boom

State of play

Longevity medicine is scaling from billionaire retreats into investable chains. Lanserhof, the luxury clinic group, secured a €95 million capital injection to open several new locations by 2030 — flagship resorts in Germany and Austria plus a Marbella site opening in 2027 — and to launch premium nutrition supplements and cosmetics, with its CEO citing accelerating global demand for preventive health and longevity medicine. One rung down the market, sleep technology is raising serious money: Ozlo, built on Bose audio IP, closed a $22 million Series B to expand its Sleepbuds and sleep-condition ecosystem, having eclipsed 200,000 customers, with partnerships across Calm and Dreem Health. And underneath both sits the structural change: health systems are starting to pay. Medicare now reimburses standardized physical activity assessments in the US Annual Wellness Visit, Australia reintroduced private-insurance rebates for selected therapies such as Pilates, and Japan allows selected expenses at government-certified exercise therapy facilities as tax-deductible medical expenses.

Why it matters

Reimbursement changes a category’s economics. A recovery studio funded by an insurer rebate, an exercise assessment coded into an annual wellness visit, or a certified facility whose programs qualify for medical tax treatment are no longer competing purely for discretionary spend — they are plugging into health budgets. That is the difference between an amenity and a service line, and it explains why capital is arriving at both ends of the market at once: institutional money for clinic chains at the top, venture money for consumer sleep hardware underneath. For mainstream operators, the opportunity is the middle — structured recovery and exercise programming with enough clinical backing to claim a share of the same payer money as the categories professionalize. The direction of travel matters more than today’s amounts: an assessment code in an annual wellness visit is modest reimbursement, but it establishes the claim that structured exercise belongs in a medical budget. Categories that get coded get prescribed, and categories that get prescribed get built into operators’ economics rather than bolted on as amenities.

Momentum call: rising, dated 2 November 2026 — clinic-chain capital, sleep-tech funding and three national health systems all moved in the same year.

What to watch

• Whether Medicare’s activity-assessment reimbursement creates a genuine referral funnel into fitness settings.
• Uptake of Australia’s rebates, and whether other markets copy Japan’s certified-facility tax treatment.
• Whether Lanserhof’s service menu migrates downmarket — supplements first, diagnostics later.
• Consolidation in sleep tech as audio, tracking and clinical partnerships converge.